Up at 5AM: The 5AM Solutions Blog

New Studies Could Lead to New Diagnostics for Alzheimer's Disease

Posted on Thu, May 21, 2015 @ 03:30 PM

Two new studies published in JAMA this week confirm that amyloid plaques on the brain predict future Alzheimer's Disease (AD). What's more, there is evidence that the plaques appear decades before patients experience the cognitive declines associated with AD. Researchers have long suspected that amyloid plaques precede the disease, but according to an article in the New York Times, this new research is "[t]he largest analysis to date of amyloid plaques in people’s brains [and it] confirms that the presence of the substance can help predict who will develop Alzheimer’s and determine who has the disease."

StillAlice

PET scans and cerebrospinal fluid testing can detect the presence of amyloid plaques long before people suffer the disabling dementia that is a hallmark of Alzheimer's. For drug developers, knowing who's got amyloid plaques early on will allow them to recruit subjects for clinical trials for drugs that might prevent or treat AD.

While this is very exciting news, there are also some cautions to note. First, if you've been following the Map of Biomedicine here on the blog, you've read that there are psychological costs associated with diagnostics that precede available treatments.

So, knowing that you've got amyloid plaques when you're in your early 30s might not be beneficial  because so far, there are no cures for or guaranteed therapies to prevent Alzheimer's. Next, even if there were, young people who have begun to develop amyloid plaques would have to weigh the pros and cons of beginning a course of treatments that could go on for decades.

Besides indicating which patients have -- or will have -- AD, researchers found that people with mild cognitive impairments (MCI) weren't always en route to Alzheimer's. People with MCI who didn't have amyloid plaques were unlikely to have Alzheimer's, thus allowing their physicians to pursue treatments for dementias caused by other factors. 

You can read the studies at JAMA here and here. And if you fell behind on the Map of Biomedicine diagnostics posts, have no fear! You can get every post with updates plus enhanced versions of the map by downloading a copy of our new ebook here.

Never Miss a Post. Subscribe!

Tags: research, clinical trials, map of biomedicine, diagnostics, Alzheimer's Disease

GET OUR BLOG IN YOUR INBOX

Diagnostic Tests on the Map of Biomedicine

MoBsmCover

Download the ebook based on our popular blog series. This free, 50+ page edition features updated, expanded posts and redesigned, easier-to-read maps. 

FREE Biobanking Ebook

Biobanking Free Ebook
Get this 29 page PDF document on how data science can be used to advance biorepositories.

 Free NGS Whitepaper

NGS White Paper for Molecular Diagnostics

Learn about the applications, opportunities and challenges in this updated free white paper. 

Recent Posts